期刊文献+

靶向抑制miRNA-21提高白血病K562细胞对阿糖胞苷的敏感性 被引量:10

Enhanced Chemosensitivty of Leukemic Cells to Cytarabine by Targeted Suppression of miRNA-21
下载PDF
导出
摘要 为研究以miRNA-21为靶标的反义核酸(AMO-miR-21)提高白血病K562细胞对阿糖胞苷(Ara-C)的敏感性及可能的作用机制,在LipofectamineTM2000介导下,将化学合成的AMO-miR-21转染K562细胞,四甲基偶氮唑蓝(MTT)法检测单独使用AMO-miR-21、Ara-C以及两者联合使用对细胞增殖抑制作用,并计算抑制率和IC50;流式细胞仪检测细胞凋亡;实时定量PCR(Real-time PCR)检测miRNA-21及其候选靶基因Pdcd4 mRNA的表达水平;免疫印迹(Western blot)检测Pdcd4蛋白的表达水平.结果显示Ara-C与AMO-miR-21联合使用后,IC50从1.95μmol/L降低到0.84μmol/L,敏感性提高到单用Ara-C的2.3倍.AMO-miR-21联合Ara-C组细胞凋亡明显增加(P<0.05).AMO-miR-21显著抑制K562细胞中miRNA-21的表达水平(P<0.05),同时Pdcd4的表达明显增加(P<0.05).提示AMO-miR-21可以提高K562细胞对Ara-C的敏感性,其作用机制与靶向抑制miRNA-21,进而诱导细胞凋亡有关. Our goal is to investigate the influences C chemosensitivity in human leukemic K562 cells, of anti-miRNA-21 oligonucleotide (AMO-miR-21) on Arawhich were incubated with different concentration of Ara- C alone or in combination with AMO-miR-21. The growth-inhibitory potencies were measured by MTT assay. The inhibition rate and IC5o was calculated. The cell apoptosis was assessed by flow cytometry. The expression of miRNA-21 and its potential target gene Pdcd4 was detected by real-time PCR and Western blot in K562 cells. Transfection of K562 cells with AMO-miR-21 enhanced the chemosensitivity of Ara-C by up to 2.3-fold and promoted Ara-C-induced cell apoptosis. Suppressing the cellular levels of miRNA-21 signifi- cantly upregulated the expression of Pdcd4. The results support a substantial role for AMO-miR-21 that enhance Ara-C sensitivity in K562 cells. The mechanism appears to be related to anti-miRNA-21-induced apoptosis, suggesting a novel potential approach to treatment of leukemia.
出处 《生命科学研究》 CAS CSCD 2011年第4期317-322,共6页 Life Science Research
基金 暨南大学科研培育与创新基金前瞻性与基础研究项目(11609406) 暨南大学研究生精品课程(医学分子生物学)建设项目(50623021)
关键词 MIRNA-21 反义寡核苷酸 阿糖胞苷 K562细胞 化疗敏感性 miRNA-21 antisense oligonucleotide Ara-C leukemia K562 cell chemosensitivity
  • 相关文献

参考文献14

  • 1SOKAL J E, LEONG S S, GOEMZ G A. Preferential inhibition by eytarabine of CFU-GM from patients with chronic granulo- cytic leukemia[J], Cancer, 1987, 59 (3): 197-202.
  • 2BLOWER P E, CHUNG H, VERDUCCI J S, et al. MicroRNAs modulate the chemosensitivity of tumor cells[J]. Molecular Can- cer Therapeutics, 2008, 7(1): 1-9.
  • 3郭敏,李育敏,费嘉,张洹.以microRNA-21为靶标的反义寡核苷酸对人白血病K562细胞的抑制作用[J].中国病理生理杂志,2009,25(6):1127-1131. 被引量:11
  • 4QI L, BART J, TAN L P, et al. Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in fiat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive car- cinoma[J]. BMC Cancer, 2009, 9: 163.
  • 5WOO H P, YEON H C, JUNG C W, et ol. Arsenic trioxide in- hibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis[J]. Biochem Biophys Res Commun, 2003, 300(1): 230-235.
  • 6金正均.合并用药中的相加[J].中国药理学报,1980,1:70-73.
  • 7戴体俊.合并用药的定量分析[J].中国药理学通报,1998,14(5):479-480. 被引量:135
  • 8MANIKANDAN J, AARTHI J J, KUMAR S D, et al. Oncomirs: The potential role of non-coding microRNAs in understanding cancer[J]. Bioinformation, 2008, 2(8): 330-334.
  • 9FRASER M, LEUNG B M, YAN X, et al. p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells[J]. Cancer Res, 2003, 63(21): 7081-7088.
  • 10AMUNDSON S A, MYERS T G, SCUDIERO D S, et al. An informatics approach identifying markers of ehemosensitivity in human cancer cell lines[J]. Cancer Research, 2000, 60(21): 6101- 6110.

二级参考文献34

  • 1Grishok A, Pasquinelli AE, Conte D, et al. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing [J]. Cell, 2001, 106(1): 23-34.
  • 2Ambros V. MicroRNA pathways in flies and worms: growth, death, fat,stress ,and timing[J]. Cell, 2003, 113(6): 673-6.
  • 3Carrington JC, Ambros V. Role of microRNAs in plant and animal development[J]. Science, 2003, 301(5631): 336-8.
  • 4Calin GA, Dumitru CD, Shimizu M, et al.Frequent deletions and down-regulation ofmicro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia [J]. Proc Natl Acad Sci USA, 2002, 99(24): 15524-9.
  • 5Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2 [J]. Proc Natl Acad Sci USA, 2005, 102(39): 13944-9.
  • 6Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis [J].Cancer Cell, 2006, 9(3): 189-98.
  • 7Kovalchuk O, Tryndyak YP, Montgomery B, et al. Estrogen-induced rat breast carcinogenesis is characterized by alterations in DNA methylation, histone modifications and aberrant microRNA expression[J]. Cell Cycle, 2007, 6(16): 2010-8.
  • 8Tavazoie SF, Alarcon C, Oskarsson T, et al. Endogenous human microRNAs that suppress breast cancer metastasis [ J ]. Nature, 2008, 451(7175): 147-52.
  • 9Yu F, Yao H, Zhu P, et al. let-7 regulates self-renewal and tumorigenesis of breast cancer cells [J]. Cell, 2007, 131 (6): 1109-23.
  • 10Mishra PJ, Humeniuk R, Mishra PJ, et al. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance [J]. Proe Natl Acad Sci USA, 2007, 104 (33): 13513-8.

共引文献272

同被引文献114

  • 1许凤娣,金志军.肿瘤的反义核酸治疗[J].国外医学(生理病理科学与临床分册),1995,15(3):149-151. 被引量:8
  • 2Nicolas FE,Lopez-Martinez AF.MicroRNAs in human diseases[J].Recent Pat DNA Gene Seq,2010,4(3):142-154.
  • 3Zhang B,Pan X,Cobb GP,et al.MicroRNAs as oncogenes and tumor suppressors[J].Dev Biol,2007,302(1):1-12.
  • 4Manikandan J,Aarthi JJ,Kumar SD,et al.Onco-mirs:the potential role of non-coding microRNAs in under-standing cancer[J].Bioinformation,2008,2(8):330-334.
  • 5Volinia S,Calin GA,Liu C-G,et al.A microRNA expression signature of human solid tumors defines cancer gene targets[J].Proc Natl Acad Sci USA,2006,103(7):2257-2261.
  • 6Iorio MV,Ferracin M,Liu CG,et al.MicroRNA gene expression deregulation in human breast cancer[J].Cancer Res,2005,65(16):7065-7070.
  • 7Chan JA,Krichevsky AM,Kosik KS.MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells[J].Cancer Res,2005,65(14):6029-6033.
  • 8Roldo C,Missiaglia E,Hagan JP,et al.MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior[J].J Clin Oncol,24(29):4677-4684.
  • 9Croce C.MicroRNAs in leukemia[J].Clin Adv Hematol Oncol,2006,4(8):577-578.
  • 10Li Y,Zhu X,Gu J,et al.Anti-miR-21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducing apoptosis[J].Cancer Sci,2010,101(4):948-954.

引证文献10

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部